Areas of Focus
- Research on mechanisms of neurodegenerative diseases and epilepsy
Work Experience
- 1993-2000 - Postdoctoral and Researcher at University College London, Department of Physiology and Pharmacology
- 2000 - Senior Researcher and Research Group Leader at Eli Lilly and Company, UK R&D Center
- 2005 - Technical Director at Shanghai Pharmaceutical Group Central Research Institute
- 2007 - Established independent laboratory at Fudan University
Academic Background & Achievements
- 1987 - Graduated from Fudan University, School of Life Sciences
- 1989-1993 - Studied PhD at University of Glasgow with Welcome Trust Scholarship
- 1995 - Received PhD in Neurophysiology
Publications
- Deficit of PKHD1L1 in the dentate gyrus increases seizure susceptibility in mice, Yu J, Wang G, Chen Z, Wan L, Zhou J, Cai J, Liu X*, Wang Y*, 2023
- Furosemide prevents membrane KCC2 downregulation during convulsant stimulation in the hippocampus, Chen L, Yu J, Wan L, Wang G, Hu Z, Wu Z, Qian B, Zhao X*, Zhang J, Liu X*, Wang Y*, 2022
- Perineuronal nets protect long-term memory by limiting activity-dependent inhibition from parvalbumin interneurons, Shi W*, Wei X, Wang X, Du S, Liu W, Song J, Wang Y*, 2019
- Thiamine diphosphate reduction strongly correlates with brain glucose hypometabolism in Alzheimer's disease, while amyloid deposition does not, Sang S, Pan X, Chen Z, Zeng F, Pan S, Liu H, Jin L, Fei G, Wang C, Ren S, Jiao F, Bao W, Zhou W, Guan Y, Zhang Y, Shi H, Wang Y, Yu X, Wang Y*, Zhong C*, 2018
- Identification of spinal circuits required to transmit touch-evoked dynamic mechanical pain, Cheng L, Duan B, Huang T, Zhang Y, Chen Y, Britz O, Garcia-Campmany L, Ren X, Vong L, Lowell BB, Goulding M, Wang Y*, Ma Q*, 2017
Awards
- Welcome Trust Scholarship (1989-1993)